decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / 220.6.12
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a Medicare national coverage determination in the National Coverage Determinations Manual. It focuses on FDG PET use in soft tissue sarcoma, the evolution of coverage status over time, and the related Medicare notice framework. The content is relevant to coders, compliance staff, reimbursement teams, and providers who need to track coverage policy changes and effective dates.
Why This Topic Matters
Coverage determinations affect whether a service is payable under Medicare and when special evidence-development pathways apply. Understanding the policy timeline helps organizations align billing, documentation, and patient access workflows with current federal guidance.
Article Sections
-
FDG PET for Soft Tissue Sarcoma (Various Effective Dates Below) – NOT COVERED
Introduces the national coverage determination topic and the overall coverage status discussed in the article.
-
Coverage Determination and Effective Dates
Summarizes the policy history, including the effective date changes and the later coverage-with-evidence-development framework.
-
Provider and Beneficiary Notification
Describes where Medicare states that providers and beneficiaries can find information about service access as available.
What You Will Learn
- How Medicare describes the coverage status for this service area
- Which effective dates are tied to the policy changes
- What general notification channels Medicare references for access information
- How this NCD fits within the National Coverage Determinations Manual
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Compliance professionals
- Revenue cycle teams
- Healthcare providers
- Utilization management staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com